Advertisement

Ocular Therapeutix Inc. of Bedford has completed enrollment of a Phase 3 clinical trial of its ReSure Sealant, a polyethylene glycol (PEG)-based hydrogel intended for use during cataract surgery, according to a statement from the company.

Advertisement
Advertisement